Abiraterone acetate, the active ingredient in Zytiga, is available as a generic medication. Abiraterone acetate is a treatment for prostate cancer.
When does Zytiga's patent expire?
The primary patents for Zytiga (abiraterone acetate) have expired, allowing for generic versions to enter the market. DrugPatentWatch.com tracks patent expiration dates for various medications, indicating that key patents protecting Zytiga have lapsed [1].
Who makes generic abiraterone acetate?
Several pharmaceutical companies manufacture and distribute generic versions of abiraterone acetate. These include manufacturers like Teva Pharmaceuticals, Accord Healthcare, and others who have received approval to market their generic products in various regions [2].
How is generic abiraterone acetate different from Zytiga?
Generic abiraterone acetate is bioequivalent to Zytiga, meaning it contains the same active ingredient and is absorbed by the body at the same rate and to the same extent [3]. The key differences typically lie in the inactive ingredients, which do not affect the drug's safety or efficacy, and in the branding and price. Generic versions are generally less expensive than the branded Zytiga.
What is the cost of generic abiraterone acetate?
The cost of generic abiraterone acetate can vary significantly depending on the pharmacy, insurance coverage, and the specific dosage and quantity. However, generic medications are typically priced lower than their brand-name counterparts. Patients and healthcare providers can compare prices across different pharmacies to find more affordable options.
What are the risks associated with generic abiraterone acetate?
The risks associated with generic abiraterone acetate are generally the same as those for branded Zytiga, as they share the same active ingredient and therapeutic indication [3]. Common side effects can include fatigue, joint pain, hot flashes, diarrhea, and elevated blood pressure [4]. More serious risks include liver problems and adrenal insufficiency [4]. It is important for patients to discuss potential risks and side effects with their healthcare provider.
What is the recommended dosage for abiraterone acetate?
The standard recommended dosage for abiraterone acetate is 1000 mg taken orally once daily, in combination with prednisone [4]. It is crucial to follow the prescribing physician's instructions regarding dosage and duration of treatment.
How does abiraterone acetate work to treat prostate cancer?
Abiraterone acetate is a CYP17A1 inhibitor. It works by blocking an enzyme called CYP17A1, which is involved in the production of androgens (male hormones) [4]. In prostate cancer, androgens can fuel tumor growth. By reducing androgen levels, abiraterone acetate helps to slow or stop the growth of prostate cancer cells, particularly in castration-resistant prostate cancer [4].
What are the indications for abiraterone acetate?
Abiraterone acetate is indicated for the treatment of metastatic castration-resistant prostate cancer (mCRPC) in adult men who have previously received docetaxel-containing chemotherapy [4]. It is also used for the treatment of mCRPC in patients who have not previously received hormone therapy [4].
*
**Sources:
[1] DrugPatentWatch.com
[2] U.S. Food & Drug Administration. (n.d.). Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations.
[3] U.S. Food & Drug Administration. (n.d.). Understanding Generic Drugs.
[4] National Cancer Institute. (n.d.). Abiraterone Acetate.